ReviewContemporary oncology (Poznan, Poland)2018
The revival of CpG oligonucleotide-based cancer immunotherapies.
Tomasz Adamus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
66 papers cite itlatest 60 shown
this papercites it